Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,261Revenue $M7,435Net Margin (%)7.5Z-Score3.0
Enterprise Value $M13,860EPS $3.8Operating Margin %13.2F-Score6
P/E(ttm))18.9Cash Flow Per Share $5.2Pre-tax Margin (%)11.4Higher ROA y-yN
Price/Book2.410-y EBITDA Growth Rate %6.3Quick Ratio0.9Cash flow > EarningsY
Price/Sales1.45-y EBITDA Growth Rate %4.3Current Ratio0.9Lower Leverage y-yY
Price/Cash Flow11.3y-y EBITDA Growth Rate %-22.4ROA % (ttm)5.8Higher Current Ratio y-yN
Dividend Yield %1.9Insider Buy (3m)0ROE % (ttm)13.6Less Shares Outstanding y-yY
Payout Ratio %26.0Shares Outstanding M144ROI % (ttm)5.5Gross Margin Increase y-yN

Gurus Latest Trades with DGX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DGXJohn Hussman 2014-12-31 Buy 1.3%$57.71 - $68.1
($63.08)
$ 71.2913%New holding, 200000 sh.200,000
DGXCharles Brandes 2014-12-31 Buy 0.18%$57.71 - $68.1
($63.08)
$ 71.2913%New holding, 186113 sh.186,113
DGXRay Dalio 2014-12-31 Add0.02%$57.71 - $68.1
($63.08)
$ 71.2913%Add 239.98%53,126
DGXRobert Olstein 2014-12-31 Reduce-0.18%$57.71 - $68.1
($63.08)
$ 71.2913%Reduce -28.05%59,000
DGXRichard Pzena 2014-12-31 Sold Out -0.14%$57.71 - $68.1
($63.08)
$ 71.2913%Sold Out0
DGXHOTCHKIS & WILEY 2014-12-31 Reduce-0.13%$57.71 - $68.1
($63.08)
$ 71.2913%Reduce -38.25%983,900
DGXJoel Greenblatt 2014-12-31 Reduce-0.09%$57.71 - $68.1
($63.18)
$ 71.2913%Reduce -62.94%88,219
DGXJoel Greenblatt 2014-09-30 Add0.14%$59.28 - $64.08
($61.73)
$ 71.2916%Add 5330.13%238,057
DGXScott Black 2014-09-30 Sold Out $59.28 - $64.08
($61.73)
$ 71.2916%Sold Out0
DGXHOTCHKIS & WILEY 2014-09-30 Reduce-0.19%$59.28 - $64.08
($61.73)
$ 71.2916%Reduce -36.86%1,593,262
DGXChris Davis 2014-06-30 Add0.8%$55.5 - $61.75
($58.56)
$ 71.2922%Add 4465.97%4,672,681
DGXScott Black 2014-06-30 Buy $55.5 - $61.75
($58.56)
$ 71.2922%New holding, 220 sh.220
DGXRichard Pzena 2014-06-30 Reduce-0.18%$55.5 - $61.75
($58.56)
$ 71.2922%Reduce -55.66%431,100
DGXRobert Olstein 2014-06-30 Reduce-0.14%$55.5 - $61.75
($58.56)
$ 71.2922%Reduce -18%82,000
DGXDavid Dreman 2014-06-30 Reduce-0.06%$55.5 - $61.75
($58.56)
$ 71.2922%Reduce -26.19%35,982
DGXJoel Greenblatt 2014-06-30 Reduce-0.06%$55.5 - $61.75
($58.56)
$ 71.2922%Reduce -94.26%4,384
DGXRay Dalio 2014-06-30 Reduce-0.03%$55.5 - $61.75
($58.56)
$ 71.2922%Reduce -82.85%13,545
DGXHOTCHKIS & WILEY 2014-03-31 Add0.1%$50.8 - $57.99
($53.53)
$ 71.2933%Add 23.69%2,495,500
DGXDavid Dreman 2014-03-31 Add0.09%$50.8 - $57.99
($53.53)
$ 71.2933%Add 66.84%48,748
DGXRay Dalio 2014-03-31 Buy 0.04%$50.8 - $57.99
($53.53)
$ 71.2933%New holding, 78977 sh.78,977
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DGX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
DGX Charles Brandes 2014-12-31186,1130.130.18New Buy
DGX John Hussman 2014-12-31200,0000.141.3New Buy
DGX Ray Dalio 2014-12-3153,1260.040.03+239.98%
DGX John Rogers 2014-12-31386,5080.270.3+10.78%
DGX Chris Davis 2014-12-315,155,6833.571.1+5.66%
DGX Brian Rogers 2014-12-313,000,0002.080.72
DGX David Dreman 2014-12-3132,4310.020.18-4.33%
DGX Robert Olstein 2014-12-3159,0000.040.48-28.05%
DGX HOTCHKIS & WILEY 2014-12-31983,9000.680.23-38.25%
DGX Joel Greenblatt 2014-12-3188,2190.060.05-62.94%
DGX Richard Pzena 2014-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


DGX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PREVOZNIK MICHAEL ESVP & General Counsel 2015-02-17Sell488$71.41-1.11view
GUINAN MARKSenior Vice President & CFO 2015-02-17Sell280$71.74-1.56view
STANZIONE DANIELDirector 2015-02-11Sell8,000$70.97-0.49view
WILENSKY GAIL RDirector 2015-02-04Sell8,000$72.34-2.38view
PFEIFFER GARY MDirector 2015-02-04Sell8,000$72.43-2.5view
ZIEGLER JOHN BDirector 2015-02-03Sell8,000$71.88-1.75view
BONGIORNO THOMAS FVP and Corporate Controller 2015-02-02Sell3,000$71.5-1.23view
BONGIORNO THOMAS FVP and Corporate Controller 2014-11-18Sell10,000$6410.34view
Cohen Jon RSVP and Chief Medical Officer 2014-11-17Sell160,029$63.1311.86view
PFEIFFER GARY MDirector 2014-11-10Sell10,000$61.6914.48view

Press Releases about DGX :

    Quarterly/Annual Reports about DGX:

    News about DGX:

    Articles On GuruFocus.com
    Charles Brandes' Top Buys During Q4 Feb 11 2015 
    A Look at John Hussman's Recent Additions to His Portfolio Feb 06 2015 
    DGX: A Healthy Diagnosis Oct 08 2014 
    The Top Five Guru-Held Mid-Cap Stocks of Q2 Sep 04 2014 
    LabCorp: A Leading Independent Diagnostic Laboratory Aug 22 2014 
    Bernard Horn Comments on Quest Diagnostics Aug 07 2014 
    Top Five Guru-Owned Mid Cap Stocks Jun 18 2014 
    Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S May 28 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S May 13 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 05 2014 

    More From Other Websites
    Quest Diagnostics Earns Fortune Magazine 2015 "World's Most Admired Companies" Designation Feb 22 2015
    Ariad Pharmaceuticals, Inc., Quest Diagnostics Inc, Amgen, Inc.: Sarissa Capital’s Top Stock Picks... Feb 21 2015
    Quest Diagnostics Earns Fortune Magazine 2015 "World's Most Admired Companies" Designation Feb 20 2015
    The Sham Of Drug Testing For Benefits: Walker, Scott And Political Pandering Feb 17 2015
    Endologix, Inc. (ELGX), Quest Diagnostics Inc (DGX), The Spectranetics Corporation (SPNC), and More:... Feb 12 2015
    Quest, Myriad Settle Patent Dispute on Breast Cancer Tests Feb 09 2015
    Quest Diagnostics and Myriad Genetics End BRCA Patent Litigation Feb 09 2015
    Quest Diagnostics and Myriad Genetics End BRCA Patent Litigation Feb 09 2015
    Quest Diagnostics Strong on Earnings, Long-Term Prospects - Analyst Blog Feb 06 2015
    Abby's Roundtable Picks for 2015 Feb 05 2015
    Why Quest Diagnostics (DGX) Stock Might be a Great Pick - Tale of the Tape Feb 05 2015
    Quest Diagnostics Inc. (DGX): New Analyst Report from Zacks Equity Research - Zacks Equity Research... Feb 05 2015
    Quest Diagnostics Q4 Earnings, Revenues Beat; Grow Y/Y - Analyst Blog Jan 29 2015
    Quest Diagnostics (DGX) Earnings Report: Q4 2014 Conference Call Transcript Jan 29 2015
    Quest Diagnostics (DGX) Beat On Q4 Earnings and Revenues - Tale of the Tape Jan 29 2015
    Quest Diagnostics Inc Earnings Call scheduled for 8:30 am ET today Jan 29 2015
    Quest Diagnostics tops Street 4Q forecasts Jan 29 2015
    Quest Diagnostics tops Street 4Q forecasts Jan 29 2015
    Quest Diagnostics Issues Strong Outlook Jan 29 2015
    QUEST DIAGNOSTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Costs... Jan 29 2015
    Q4 2014 Quest Diagnostics Inc Earnings Release - Before Market Open Jan 29 2015
    Quest Diagnostics Reports Fourth Quarter and Full Year 2014 Financial Results; Provides Guidance For... Jan 29 2015
    Morgan Stanley Previews Earnings For Cardinal Health, Quest Diagnostics Jan 28 2015
    Quest Diagnostics and CDC Expand Public Health Collaboration to Improve Hepatitis Diagnosis and... Jan 28 2015
    Quest Diagnostics and CDC Expand Public Health Collaboration to Improve Hepatitis Diagnosis and... Jan 28 2015
    Will Quest Diagnostics' (DGX) Earnings Surprise in Q4? - Analyst Blog Jan 27 2015
    Quest Diagnostics To Release Fourth Quarter And Full Year 2014 Financial Results On January 29 Jan 13 2015
    Quest Diagnostics to Speak at the Goldman Sachs Healthcare CEOs Unscripted Conference Jan 05 2015
    FDA Clears the Focus Diagnostics Simplexa™ Flu A/B & RSV Direct Test to Include Eight Circulating... Dec 09 2014
    Quest Diagnostics Declares Quarterly Cash Dividend Dec 04 2014
    Quest Diagnostics To Speak At The Piper Jaffray 26th Annual Healthcare Conference Dec 01 2014
    OPTIMIZERx Corp. to Automate Patient Savings and Improve Medication Adherence for Patients Served by... Nov 17 2014
    Quest Diagnostics Discusses Progress in Executing Strategy to Drive Shareholder Value and Presents... Nov 05 2014
    Quest Diagnostics beats Street 3Q forecasts Oct 23 2014
    Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors Oct 22 2014
    Russia sanctions worry hits Wall Street; techs weigh Mar 26 2014
    Focus Diagnostics Receives FDA Clearance for Moderate Complexity Simplexa® HSV 1 & 2 Direct... Mar 24 2014
    Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering Mar 12 2014
    Quest Diagnostics to Acquire Summit Health Mar 12 2014
    Quest Diagnostics Completes Acquisition of Solstas Lab Partners and Raises 2014 Financial Guidance Mar 10 2014
    Quest Diagnostics to Present Interoperability Solutions for Health Systems at HIMSS 2014 Feb 27 2014
    Quest Diagnostics Expands Hereditary Cancer Screening Offering with Lynch Syndrome Blood and Biopsy... Feb 27 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK